NKT Therapeutics Inc. Presents Data on Potential Antibody Treatment for Sickle Cell Disease
12/6/2012 9:48:21 AM
More...
|
DSM Pharmaceutical Products and NKT Therapeutics Inc. Sign Contract for Lead Product Development and Manufacture
2/8/2011 10:21:39 AM
More...
|
DSM Biologics and NKT Therapeutics Inc. Sign Contract for Lead Product Development and Manufacture
2/8/2011 8:05:42 AM
More...
|
NKT Therapeutics Inc. Announces Hiring of Barbara Finck, M.D. as Chief Medical Officer
10/5/2010 10:36:45 AM
More...
|
BioWa and NKT Therapeutics Inc. Announce Licensing of BioWa's POTELLIGENT(R) Technology For Use in Antibody Research and Development
10/21/2009 9:34:57 AM
More...
|
Selexis SA and NKT Therapeutics Inc. Enter Into Research Services Agreement
9/1/2009 11:05:09 AM
More...
|
NKT Therapeutics Inc. Broadens Scientific Advisory Board with Three New Appointments
7/27/2009 8:36:40 AM
More...
|
Antitope, Announces Antibody Research Agreement With NKT Therapeutics Inc.
4/9/2009 12:39:43 PM
More...
|
NKT Therapeutics Inc. Closes Series A Venture Round Led by SV Life Sciences and MedImmune Ventures, Inc.
3/16/2009 7:23:43 AM
More...
|